Richard D. Sloan
Haining, 314400, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
The HIV-1 restriction factor RPRD2 does not inhibit transcription of HIV-1 or endogenous retroelements.
Journal: bioRxiv : the preprint server for biology
Published: August 01, 2026
Structure-Function Correlations of Commercial Fucoidan Extracts: Antioxidant, Antiviral, Antifungal, Antibacterial and Prebiotic Activities.
Journal: Molecules (Basel, Switzerland)
Published: March 30, 2026
Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats.
Journal: PLoS pathogens
Published: January 30, 2024
The innate immune factor RPRD2/REAF and its role in the Lv2 restriction of HIV.
Journal: mBio
Published: October 26, 2023
IFITM proteins: Understanding their diverse roles in viral infection, cancer, and immunity.
Journal: The Journal of biological chemistry
Published: June 24, 2022
The Role of IFITM Proteins in Tick-Borne Encephalitis Virus Infection.
Journal: Journal of virology
Published: October 06, 2021
Priming of NLRP3 inflammasome activation by Msn kinase MINK1 in macrophages.
Journal: Cellular & molecular immunology
Published: April 16, 2021
HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.
Journal: Journal of virology
Published: September 18, 2019
Phosphatase PP2A is essential for TH17 differentiation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 30, 2018
RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction.
Journal: Journal of virology
Published: June 24, 2016
Last Updated: 09/26/2026